Fluorodopa F18 has 5 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Benserazide, Carbidopa, Dopamine Agonists. Patients taking Fluorodopa F18 should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Moderate
- 5
Moderate (5)
- Fluorodopa F18 + Benserazide— AADC inhibitor that may increase Fluorodopa F18 bioavailability to the brain by inhibiting peripheral decarboxylase acti…
- Fluorodopa F18 + Carbidopa— AADC inhibitor that may increase Fluorodopa F18 bioavailability to the brain by inhibiting peripheral decarboxylase acti…
- Fluorodopa F18 + Dopamine Agonists— May interfere with Fluorodopa F18 imaging. Consider discontinuing 12 hours before administration if safely possible.
- Fluorodopa F18 + Mao Inhibitors— Peripheral COMT inhibitors may interfere with Fluorodopa F18 imaging. Consider discontinuing 12 hours before administrat…
- Fluorodopa F18 + Monoamine Oxidase Inhibitors (Maois)— May interfere with Fluorodopa F18 imaging. Consider discontinuing 12 hours before administration if safely possible.